Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIQG.L Regulatory News (IQG)

  • There is currently no data for IQG

Trading Statement

21 Jan 2015 07:00

RNS Number : 6885C
Ubisense Group PLC
21 January 2015
 



 



21 January 2015

 

UBISENSE PLC - YEAR-END UPDATE

 

 

Ubisense Group PLC ("Ubisense" or the "Group") gives the following update on trading for its financial year ended 31 December 2014.

The second half of 2014 saw significant progress in moving the revenue mix towards a greater proportion of higher margin solutions sales. This has driven an encouraging increase in Adjusted EBITDA during the second half of the year. Second half revenues were marginally ahead of the first half, however were below the Board's expectations mainly as a result of slippage on two larger contracts now expected to sign in the first half of 2015. The Board nevertheless expects Adjusted EBITDA for 2014 be in line with its expectations.

During the second half, the Group incurred restructuring and further integration costs of approximately £0.7m relating both to the rationalisation of our services division headcount and the acquisition of Geoplan. These are exceptional items, and are non-recurring. Full year results will also reflect a non-cash charge of approximately £1.2m relating to the impairment of goodwill on certain non-core services division assets due to our changing focus towards IP we have developed ourselves and which will produce enhanced margins in the core business.

Cash balances at the year-end were approximately £3.7m, similar to last year's figure. The Group's net debt position was £3.2m at the year-end, from net cash of £0.75m at the half year, primarily as a result of an increase of approximately £4.5m in trade debtors, reflecting the sales profile over the period, and which is expected to reverse over the first quarter.

 

Given the healthy new orders intake, which comprises a higher proportion of solutions revenues and a consequent enhanced margin profile, the Group expects to fund its organic business growth through cash flow and bank facilities during 2015.

Ubisense CEO Richard Green, said: "We are making solid progress towards our goals, with margins and cash set to improve during 2015. Our shareholders have been very patient as we make the transition from being a Cambridge tech market newcomer to a focused, profitable enterprise software business, with very large international customers in growth markets. This is now well under way."

For further information contact

Ubisense Group plc +44 (0) 1223 535170

Richard Green, Chief Executive

Robert Parker, Chief Financial Officer

 

Numis Securities Limited +44 (0) 7260 1000

 

Simon Willis, James Lillywhite

(Corporate Finance)

Rupert Krefting

(Corporate Broking)

 

Montfort Communications +44 (0) 20 3514 0897

 

Nick Miles +44 (0) 7973 130669

 

About Ubisense

Ubisense is a market leader in real time location intelligence solutions that enable companies to optimise their business processes. By keeping track of key assets, Ubisense solutions bring clarity to complex operations while also improving quality and reliability. Ubisense solutions are used by a number of blue chip customers across the world, such as AGCO, Airbus, Aston Martin, BMW, Cablevision, Daimler, Deutsche Telekom, Duke Energy, MINI and VW.

Ubisense is headquartered in Cambridge, UK, with offices in the USA; Canada; France; Germany; Japan; Korea; Philippines and Singapore. For more information visit: www.ubisense.net

For more information about Ubisense and Ubisense Smart Factory visit: www.ubisense.net

 

 

 

 

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTVBLFLEFFZBBK
Date   Source Headline
27th Mar 20177:00 amRNSDirectors' Dealings
22nd Mar 20177:00 amRNSDirectors' Dealings
21st Mar 20177:00 amRNSFinal Results
16th Mar 20177:00 amRNSNotice of Results
1st Mar 20172:39 pmRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Feb 20175:07 pmRNSTR-1: Notifications of Major Interests in Shares
8th Feb 20177:00 amRNSTR-1: NOTIFICATION OF MAJOR INTEREST IN SHARES
27th Jan 20177:00 amRNSTrading Statement
3rd Jan 20177:00 amRNSBlock listing Interim Review
15th Dec 20167:00 amRNSAppointment of CEO
15th Dec 20167:00 amRNSDirectors Dealings
25th Nov 20165:37 pmRNSDirectors' Dealings
8th Nov 20167:00 amRNSDirectors' Dealings
27th Oct 20164:18 pmRNSDirectors' Dealings
14th Sep 20167:00 amRNSDirector/PDMR Shareholding
16th Aug 20167:00 amRNSInterim Results
10th Aug 20167:00 amRNSAppointment of CFO
1st Jul 20167:00 amRNSTotal Voting Rights
22nd Jun 201611:02 amRNSResult of AGM
27th May 20167:00 amRNSNotice of AGM
18th May 20167:00 amRNSDirector resignation & appointment
28th Apr 201611:28 amRNSHolding(s) in Company
27th Apr 20162:58 pmRNSHolding(s) in Company
26th Apr 20165:48 pmRNSHolding(s) in Company
26th Apr 20168:00 amRNSDirector's Dealing
25th Apr 20163:18 pmRNSResult of General Meeting
7th Apr 201610:40 amRNS£4.8 million placing
7th Apr 201610:33 amRNSFinal Results
17th Mar 20167:00 amRNSNotice of Results
17th Mar 20167:00 amRNSNew contracts
9th Feb 20167:00 amRNSHolding(s) in Company
25th Jan 20167:00 amRNSTrading Statement
4th Jan 20167:00 amRNSBlocklisting Interim Review
4th Jan 20167:00 amRNSTotal Voting Rights
2nd Dec 20159:20 amRNSDirector/PDMR Shareholding
2nd Dec 20157:00 amRNSHolding(s) in Company
2nd Dec 20157:00 amRNSHolding(s) in Company
1st Dec 20157:00 amRNSTotal Voting Rights
27th Nov 20157:00 amRNSHolding(s) in Company
27th Nov 20157:00 amRNSHolding(s) in Company
23rd Nov 20157:00 amRNSHolding(s) in Company
12th Nov 20157:00 amRNSTrading Update
2nd Nov 20157:00 amRNSTotal Voting Rights
2nd Oct 20157:00 amRNSTotal Voting Rights
16th Sep 20157:00 amRNSHolding(s) in Company
2nd Sep 201511:45 amRNSTotal Voting Rights
1st Sep 20157:04 amRNSHolding(s) in Company
17th Aug 20157:00 amRNSInterim Results
8th Jul 20157:00 amRNSHolding(s) in Company
3rd Jul 20157:00 amRNSTrading Update

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.